Cargando…

Methodology of drug screening and target identification for new necroptosis inhibitors

Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Pengchao, Cai, Zhenyu, Zhuang, Chunlin, Chen, Xiaofei, Chai, Yifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460297/
https://www.ncbi.nlm.nih.gov/pubmed/31011462
http://dx.doi.org/10.1016/j.jpha.2018.11.002
_version_ 1783410307637444608
author Pan, Pengchao
Cai, Zhenyu
Zhuang, Chunlin
Chen, Xiaofei
Chai, Yifeng
author_facet Pan, Pengchao
Cai, Zhenyu
Zhuang, Chunlin
Chen, Xiaofei
Chai, Yifeng
author_sort Pan, Pengchao
collection PubMed
description Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases. Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers. Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years. In addition, the identification of the critical drug targets of the necroptosis is also discussed.
format Online
Article
Text
id pubmed-6460297
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Xi'an Jiaotong University
record_format MEDLINE/PubMed
spelling pubmed-64602972019-04-22 Methodology of drug screening and target identification for new necroptosis inhibitors Pan, Pengchao Cai, Zhenyu Zhuang, Chunlin Chen, Xiaofei Chai, Yifeng J Pharm Anal Review Paper Apoptosis has been considered as the only form of regulated cell death for a long time. However, a novel form of programmed cell death called necroptosis was recently reported. The process of necroptosis is regulated and plays a critical role in the occurrence and development of multiple human diseases. Thus, the study on the molecular mechanism of necroptosis and its effective inhibitors has been an attractive field for researchers. Herein, we introduce the molecular mechanism of necroptosis and focus on the literature about necroptosis drug screening in recent years. In addition, the identification of the critical drug targets of the necroptosis is also discussed. Xi'an Jiaotong University 2019-04 2018-11-27 /pmc/articles/PMC6460297/ /pubmed/31011462 http://dx.doi.org/10.1016/j.jpha.2018.11.002 Text en © 2018 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Paper
Pan, Pengchao
Cai, Zhenyu
Zhuang, Chunlin
Chen, Xiaofei
Chai, Yifeng
Methodology of drug screening and target identification for new necroptosis inhibitors
title Methodology of drug screening and target identification for new necroptosis inhibitors
title_full Methodology of drug screening and target identification for new necroptosis inhibitors
title_fullStr Methodology of drug screening and target identification for new necroptosis inhibitors
title_full_unstemmed Methodology of drug screening and target identification for new necroptosis inhibitors
title_short Methodology of drug screening and target identification for new necroptosis inhibitors
title_sort methodology of drug screening and target identification for new necroptosis inhibitors
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460297/
https://www.ncbi.nlm.nih.gov/pubmed/31011462
http://dx.doi.org/10.1016/j.jpha.2018.11.002
work_keys_str_mv AT panpengchao methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors
AT caizhenyu methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors
AT zhuangchunlin methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors
AT chenxiaofei methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors
AT chaiyifeng methodologyofdrugscreeningandtargetidentificationfornewnecroptosisinhibitors